Lobe Sciences Ltd. (LOBE.CN)
CAD 0.02
(-42.86%)
CAD 0.02
(-42.86%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 192.35 Thousand CAD | 121.19% |
| 2022 | -907.53 Thousand CAD | 20.52% |
| 2021 | -1.14 Million CAD | -978.93% |
| 2020 | 129.91 Thousand CAD | 125.34% |
| 2019 | -512.77 Thousand CAD | -19191.84% |
| 2018 | -2658.00 CAD | 91.0% |
| 2017 | -29.52 Thousand CAD | 14.47% |
| 2016 | -34.52 Thousand CAD | 56.5% |
| 2015 | -79.36 Thousand CAD | 44.94% |
| 2014 | -144.13 Thousand CAD | 42.34% |
| 2013 | -249.98 Thousand CAD | 27.17% |
| 2012 | -343.23 Thousand CAD | -515.69% |
| 2011 | -55.74 Thousand CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 309.45 Thousand CAD | 60.88% |
| 2024 Q3 | 2.18 Million CAD | 501.65% |
| 2024 Q2 | 363.05 Thousand CAD | 17.32% |
| 2023 Q1 | -449.41 Thousand CAD | 50.48% |
| 2023 Q2 | 39.29 Thousand CAD | 108.74% |
| 2023 Q4 | 192.35 Thousand CAD | 141.43% |
| 2023 Q3 | -464.23 Thousand CAD | -1281.41% |
| 2023 FY | 192.35 Thousand CAD | 121.19% |
| 2022 FY | -907.53 Thousand CAD | 20.52% |
| 2022 Q1 | -1.44 Million CAD | -26.45% |
| 2022 Q4 | -907.53 Thousand CAD | -9.64% |
| 2022 Q3 | -827.75 Thousand CAD | 26.61% |
| 2022 Q2 | -1.12 Million CAD | 21.88% |
| 2021 Q2 | -1.79 Million CAD | -1300.61% |
| 2021 Q3 | -2.32 Million CAD | -29.31% |
| 2021 FY | -1.14 Million CAD | -978.93% |
| 2021 Q4 | -1.14 Million CAD | 50.89% |
| 2021 Q1 | 149.76 Thousand CAD | 15.28% |
| 2020 Q1 | 200.45 Thousand CAD | 139.09% |
| 2020 FY | 129.91 Thousand CAD | 125.34% |
| 2020 Q2 | 278.38 Thousand CAD | 38.87% |
| 2020 Q4 | 129.91 Thousand CAD | -64.25% |
| 2020 Q3 | 363.34 Thousand CAD | 30.52% |
| 2019 Q2 | 5763.00 CAD | 316.82% |
| 2019 FY | -512.77 Thousand CAD | -19191.84% |
| 2019 Q3 | -1.31 Million CAD | -22873.38% |
| 2019 Q4 | -512.77 Thousand CAD | 60.93% |
| 2019 Q1 | -2658.00 CAD | 33.96% |
| 2018 Q2 | -18.09 Thousand CAD | 38.72% |
| 2018 Q1 | -29.52 Thousand CAD | 31.27% |
| 2018 FY | -2658.00 CAD | 91.0% |
| 2018 Q3 | -10.11 Thousand CAD | 44.1% |
| 2018 Q4 | -4025.00 CAD | 60.21% |
| 2017 Q4 | -42.96 Thousand CAD | 25.97% |
| 2017 FY | -29.52 Thousand CAD | 14.47% |
| 2017 Q3 | -58.03 Thousand CAD | 22.62% |
| 2017 Q2 | -75 Thousand CAD | -117.26% |
| 2017 Q1 | -34.52 Thousand CAD | 13.26% |
| 2016 FY | -34.52 Thousand CAD | 56.5% |
| 2016 Q2 | -66.26 Thousand CAD | 16.51% |
| 2016 Q4 | -39.8 Thousand CAD | 24.95% |
| 2016 Q3 | -53.02 Thousand CAD | 19.97% |
| 2016 Q1 | -79.36 Thousand CAD | 13.34% |
| 2015 FY | -79.36 Thousand CAD | 44.94% |
| 2015 Q4 | -91.57 Thousand CAD | 12.12% |
| 2015 Q3 | -104.2 Thousand CAD | 10.29% |
| 2015 Q2 | -116.15 Thousand CAD | 19.41% |
| 2015 Q1 | -144.13 Thousand CAD | 10.86% |
| 2014 Q3 | -189.86 Thousand CAD | 14.46% |
| 2014 Q1 | -249.98 Thousand CAD | 10.1% |
| 2014 FY | -144.13 Thousand CAD | 42.34% |
| 2014 Q2 | -221.94 Thousand CAD | 11.22% |
| 2014 Q4 | -161.68 Thousand CAD | 14.84% |
| 2013 Q3 | -308.44 Thousand CAD | 10.15% |
| 2013 Q1 | -343.23 Thousand CAD | 2.0% |
| 2013 Q2 | -343.28 Thousand CAD | -0.02% |
| 2013 Q4 | -278.05 Thousand CAD | 9.85% |
| 2013 FY | -249.98 Thousand CAD | 27.17% |
| 2012 Q2 | -25.13 Thousand CAD | 54.91% |
| 2012 FY | -343.23 Thousand CAD | -515.69% |
| 2012 Q1 | -55.74 Thousand CAD | 0.0% |
| 2012 Q3 | -381.49 Thousand CAD | -1417.84% |
| 2012 Q4 | -350.24 Thousand CAD | 8.19% |
| 2011 FY | -55.74 Thousand CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aion Therapeutic Inc. | 826.13 Thousand CAD | 76.717% |
| Ayurcann Holdings Corp. | 69.97 Thousand CAD | -174.868% |
| Blueberries Medical Corp. | -805.35 Thousand CAD | 123.884% |
| The BC Bud Corporation | 225.15 Thousand CAD | 14.569% |
| BioNxt Solutions Inc. | 4.53 Million CAD | 95.754% |
| CordovaCann Corp. | 6.13 Million CAD | 96.863% |
| Christina Lake Cannabis Corp. | 4.62 Million CAD | 95.844% |
| Captor Capital Corp. | -5.41 Million CAD | 103.555% |
| City View Green Holdings Inc. | 1.49 Million CAD | 87.161% |
| 1CM Inc. | 3.31 Million CAD | 94.198% |
| Global Hemp Group Inc. | 3.55 Million CAD | 94.585% |
| Greenway Greenhouse Cannabis Corporation | 14.48 Million CAD | 98.672% |
| IM Cannabis Corp. | 11.96 Million CAD | 98.393% |
| Maple Leaf Green World Inc. | 2.47 Million CAD | 92.225% |
| Mountain Valley MD Holdings Inc. | -5.91 Million CAD | 103.252% |
| Nextleaf Solutions Ltd. | -449.15 Thousand CAD | 142.825% |
| Ovation Science Inc. | 143.76 Thousand CAD | -33.794% |
| Pharmadrug Inc. | 1.2 Million CAD | 84.06% |
| Captiva Verde Wellness Corp. | 186.26 Thousand CAD | -3.27% |
| RAMM Pharma Corp. | -4.71 Million CAD | 104.082% |
| RIV Capital Inc. | -101.38 Million CAD | 100.19% |
| Revive Therapeutics Ltd. | -797.85 Thousand CAD | 124.109% |
| Red White & Bloom Brands Inc. | 259.87 Million CAD | 99.926% |
| SLANG Worldwide Inc. | 20.83 Million CAD | 99.077% |
| 1933 Industries Inc. | 16.47 Million CAD | 98.833% |
| Red Light Holland Corp. | -13.56 Million CAD | 101.418% |
| Top Strike Resources Corp. | 13.24 Million CAD | 98.548% |
| Xebra Brands Ltd. | -102.41 Thousand CAD | 287.809% |
| Adastra Holdings Ltd. | 2.2 Million CAD | 91.274% |